John McCamant, editor of the Medical Technology Stock Letter, urges his readers not to bail on biotech.
Overvaluation is also a theme with John McCamant, co-editor of the Medical Technology Stock Letter in Berkeley, Calif.
Jim McCament, editor of the Medical Technology Stock Letter, speculated in an update yesterday that some investors were simply selling on the news, a trend he said he sees often with small biotech stocks.
Matt Berry, associate analyst at John McCamant's Medical Technology Stock Letter, says much of the malaise in the current market is fallout from the ImClone (nasdaq: IMCL - news - people ) fiasco.
In a letter dated Jan. 13, Deephaven Capital Management, one of the ten largest holders of Guidant stock, told Guidant's board that the Boston Scientific offer was clearly superior.
With the ink barely dry on his resignation letter, signed that August, it is hardly a stretch to conclude that a sizable sale of stock in early September indicates that Skilling knew about liquidity problems at Enron.
Randy Williams Gurian , editor of Seattle-based Tech Stock Insights, told his subscribers in last month's letter about four Internet survivors that they should consider buying.
On the face of the FDA's "not approvable" letter alone, the punishment meted out to Alkermes' stock seems unfair.
Inwentash says interest in the stock has been driven by James Dines, a gold fan who runs the Dines Letter out of Belvedere, Calif.
Murphy's oldest publication, California Technology Stock Letter, has fared much worse: down 53.8% for the first half of 2002 and returning an average of negative 36.5% a year for the last five years.
In a New Year letter to investors, David Einhorn listed gold as one of his Greenlight fund's top five holdings along with stock in Apple, Cigna, General Motors and Vodafone.
In a letter dated Monday, Buffett said he planned to give away 12, 050, 000 Class B shares of Berkshire Hathaway stock to five foundations.
应用推荐